|
|
|
|
Vol. 15, Issue 12, 5470-5480, December 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Departments of Medicine and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093-0650;
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139
Submitted March 19, 2004;
Revised September 13, 2004;
Accepted September 14, 2004
Monitoring Editor: Juan S. Bonifacino
Ligand binding to cell surface receptors initiates both signal transduction and endocytosis. Although signaling may continue within the endocytic compartment, down-regulation is the major mechanism that controls the concentration of cell surface receptors, their ability to receive environmental signals, and the ultimate strength of biological signaling. Internalization, recycling, and trafficking of receptor tyrosine kinases (RTKs) within the endosome compartment are each regulated to control the overall process of down-regulation. We have identified the Na+/H+ exchanger regulatory factor (NHERF) as an important molecular component that stabilizes epidermal growth factor receptors (EGFRs) at the cell surface to restrict receptor down-regulation. The NH2-terminal PDZ domain (PDZ 1) of NHERF specifically binds to an internal peptide motif located within the COOH-terminal regulatory domain of EGFR. Expression of NHERF slows the rate of EGF-induced receptor degradation. A point mutation that abolishes the PDZ 1 recognition sequence of EGFR enhances the rate of ligand-induced endocytosis and down-regulation of EGFR. Similarly, expression of a dominant negative mutant of NHERF enhances EGF-induced receptor down-regulation. In contrast to
-adrenergic receptors where NHERF enhances recycling of internalized receptors, NHERF stabilizes EGFR at the cell surface and slows the rate of endocytosis without affecting recycling. Although the mechanisms differ, for both RTKs and G protein-coupled receptors, the overall effect of NHERF is to enhance the fraction of receptors present at the cell surface.
Abbreviations used: CFTR, cycstic fibrosis transmembrane conductance regulator; EGFR, epidermal growth factor receptor; ERM, Ezrin, Radizin, Moesin binding domain; GPCR, G protein-coupled receptor; NHERF, Na+/H+ exchanger regulatory factor; PDZ, domain initially identified in PSD 95, discs large and Z0-1 proteins; RTK, receptor tyrosine kinase.
Corresponding author. E-mail address: ggill{at}ucsd.edu.
This article has been cited by other articles:
![]() |
B. K. Cole, M. Curto, A. W. Chan, and A. I. McClatchey Localization to the Cortical Cytoskeleton Is Necessary for Nf2/Merlin-Dependent Epidermal Growth Factor Receptor Silencing Mol. Cell. Biol., February 15, 2008; 28(4): 1274 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Curto, B. K. Cole, D. Lallemand, C.-H. Liu, and A. I. McClatchey Contact-dependent inhibition of EGFR signaling by Nf2/Merlin J. Cell Biol., June 21, 2007; 177(5): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stasyk, N. Schiefermeier, S. Skvortsov, H. Zwierzina, J. Peranen, G. K. Bonn, and L. A. Huber Identification of Endosomal Epidermal Growth Factor Receptor Signaling Targets by Functional Organelle Proteomics Mol. Cell. Proteomics, May 1, 2007; 6(5): 908 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mitsushima, K. Ueda, and N. Kioka Vinexin beta regulates the phosphorylation of epidermal growth factor receptor on the cell surface. Genes Cells, September 1, 2006; 11(9): 971 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuwasako, Y.-N. Cao, C.-P. Chu, S. Iwatsubo, T. Eto, and K. Kitamura Functions of the Cytoplasmic Tails of the Human Receptor Activity-modifying Protein Components of Calcitonin Gene-related Peptide and Adrenomedullin Receptors J. Biol. Chem., March 17, 2006; 281(11): 7205 - 7213. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Odell, J. L. Scott, and D. F. Van Helden Epidermal Growth Factor Induces Tyrosine Phosphorylation, Membrane Insertion, and Activation of Transient Receptor Potential Channel 4 J. Biol. Chem., November 11, 2005; 280(45): 37974 - 37987. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. McClatchey and M. Giovannini Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin Genes & Dev., October 1, 2005; 19(19): 2265 - 2277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bomberger, W. S. Spielman, C. S. Hall, E. J. Weinman, and N. Parameswaran Receptor Activity-modifying Protein (RAMP) Isoform-specific Regulation of Adrenomedullin Receptor Trafficking by NHERF-1 J. Biol. Chem., June 24, 2005; 280(25): 23926 - 23935. [Abstract] [Full Text] [PDF] |
||||